Retroviral vector performance in defined chromosomal loci of modular packaging cell lines

Human Gene Therapy

Volumn 21, Issue 8, 2010, Pages 979-991

  Gama Norton, L ^a,b   Herrmann, S ^a   Schucht, R ^a   Coroadinha, A S ^b   Low R ^c   Alves, P M ^b   Bartholomae, C C ^d   Schmidt, M ^d   Baum, C ^e   Schambach, A ^e   Hauser, H ^a   Wirth, D ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c BIONTECH AG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

ARTICLE; CELL LINE; CHROMOSOME; DNA INTEGRATION; DRUG SAFETY; DRUG SCREENING; GENE FREQUENCY; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; PROMOTER REGION; RNA TRANSCRIPTION;

CELL LINE; CHROMOSOMES; GENE TARGETING; GENE THERAPY; GENETIC LOCI; GENETIC VECTORS; PROMOTER REGIONS, GENETIC; RETROVIRIDAE; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY; VIRUS INTEGRATION;

EID: 77955506625     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.089     Document Type: Article

References (33)

1. Coroadinha, A.S., Schucht, R., Gama-Norton, L., Wirth, D., Hauser, H., and Carrondo, M.J. (2006). The use of Flp/FRT recombinase cassette in retroviral vector producer cell lines: flexibility and efficiency in transgene exchange. J. Biotechnol. 124, 457-468.
2. Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., and Collins, M.K. (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
3. Danos, O., and Mulligan, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and eco-tropic host ranges. Proc. Natl. Acad. Sci. U.S.A. 85, 6460-6464.
4. Edelstein, M.L., Abedi, M.R., and Wixon, J. (2007). Gene therapy clinical trials worldwide to 2007\an update. J. Gene Med. 9, 833-842.
5. Furger, A., Monks, J., and Proudfoot, N.J. (2001). The retro-viruses human immunodeficiency virus type 1 and Moloney murine leukemia virus adopt radically different strategies to regulate promoter-proximal polyadenylation. J. Virol. 75, 11735-11746.
6. Gabriel, R., Eckenberg, R., Paruzynski, A., Bartholomae, C.C., Nowrouzi, A., Arens, A., Howe, S.J., Recchia, A., Cattoglio, C., Wang, W., Faber, K., Schwarzwaelder, K., Kirsten, R., Deich-mann, A., Ball, C.R., Balaggan, K.S., Yanez-Munoz, R.J., Ali, R.R., Gaspar, H.B., Biasco, L., Aiuti, A., Cesana, D., Montini, E., Naldini, L., Cohen-Haguenauer, O., Mavilio, F., Thrasher, A.J., Glimm, H., von Kalle, C., Saurin, W., and Schmidt, M. (2009). Comprehensive genomic access to vector integration in clinical gene therapy. Nat. Med. 15, 1431-1436.
7. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., De Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Mac-intyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
8. Herman, S.A., and Coffin, J.M. (1987). Efficient packaging of readthrough RNA in ALV: Implications for oncogene trans-duction. Science 236, 845-848.
9. Kraunus, J., Schaumann, D.H., Meyer, J., Modlich, U., Fehse, B., Brandenburg, G., Von Laer, D., Klump, H., Schambach, A., Bohne, J., and Baum, C. (2004). Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11, 1568-1578.
10. Levine, K.L., Steiner, B., Johnson, K., Aronoff, R., Quinton, T.J., and Linial, M.L. (1990). Unusual features of integrated cDNAs generated by infection with genome-free retroviruses. Mol. Cell. Biol. 10, 1891-1900.
11. Linial, M. (1987). Creation of a processed pseudogene by retro-viral infection. Cell 49, 93-102.
12. Loew, R., Meyer, Y., Kuehlcke, K., Gama-Norton, L., Wirth, D., Hauser, H., Stein, S., Grez, M., Thornhill, S., Thrasher, A., Baum, C., and Schambach, A. (2010). A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther. 17, 272-280.
13. Lum, R., and Linial, M.L. (1998). Retrotransposition of nonviral RNAs in an avian packaging cell line. J. Virol. 72, 4057-4064.
14. Markowitz, D., Goff, S., and Bank, A. (1988). A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
15. Miller, A.D., and Chen, F. (1996). Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70, 5564-5571.
16. Miller, A.D., Garcia, J.V., von Suhr, N., Lynch, C.M., Wilson, C., and Eiden, M.V. (1991). Construction and properties of ret-rovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
17. Muriaux, D., and Rein, A. (2003). Encapsidation and transduction of cellular genes by retroviruses. Front. Biosci. 8, d135-d142.
18. Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406.
19. Ramirez-Solis, R., Rivera-Perez, J., Wallace, J.D., Wims, M., Zheng, H., and Bradley, A. (1992). Genomic DNA micro-extraction: A method to screen numerous samples. Anal. Biochem. 201, 331-335.
20. Schambach, A., Bohne, J., Baum, C., Hermann, F.G., Egerer, L., von Laer, D., and Giroglou, T. (2006a). Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 13, 641-645.
21. Schambach, A., Mueller, D., Galla, M., Verstegen, M.M., Wage-maker, G., Loew, R., Baum, C., and Bohne, J. (2006b). Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13, 1524-1533.
22. Schambach, A., Galla, M., Maetzig, T., Loew, R., and Baum, C. (2007). Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol. Ther. 15, 1167-1173.
23. Schucht, R., Coroadinha, A.S., Zanta-Boussif, M.A., Verhoeyen, E., Carrondo, M.J., Hauser, H., and Wirth, D. (2006). A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol. Ther. 14, 285-292.
24. Schwartz, J.R., Duesberg, S., and Duesberg, P.H. (1995). DNA recombination is sufficient for retroviral transduction. Proc. Natl. Acad. Sci. U.S.A. 92, 2460-2464.
25. Swain, A., and Coffin, J.M. (1992). Mechanism of transduction by retroviruses. Science 255, 841-845.
26. Swanstrom, R., Parker, R.C., Varmus, H.E., and Bishop, J.M. (1983). Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc. Natl. Acad. Sci. U.S.A. 80, 2519-2523.
27. Uren, A.G., Kool, J., Berns, A., and van Lohuizen, M. (2005). Retroviral insertional mutagenesis: Past, present and future. Oncogene 24, 7656-7672.
28. Verhoeyen, E., Hauser, H., and Wirth, D. (2001). Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum. Gene Ther. 12, 933-944.
29. Ward, M., Sattler, R., Grossman, I.R., Bell, A.J., Jr., Skerrett, D., Baxi, L., and Bank, A. (2003). A stable murine-based RD114 retroviral packaging line efficiently transduces human hema-topoietic cells. Mol. Ther. 8, 804-812.
30. Yu, S.F., von Ruden, T., Kantoff, P.W., Garber, C., Seiberg, M., Ruther, U., Anderson, W.F., Wagner, E.F., and Gilboa, E. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 83, 3194-3198.
31. Zaiss, A.K., Son, S., and Chang, L.J. (2002). RNA 3 readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. J. Virol. 76, 7209-7219.
32. Zufferey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory el-ement enhances expression of transgenes delivered by retro-viral vectors. J. Virol. 73, 2886-2892.
33. Zychlinski, D., Schambach, A., Modlich, U., Maetzig, T., Meyer, J., Grassman, E., Mishra, A., and Baum, C. (2008). Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol. Ther. 16, 718-725.